Michael Taylor is listed as an executive officer and director on 5 SEC Form D filings by 3 issuers between Oct 2009 and Jul 2016: Deciphera Pharmaceuticals, LLC (Waltham, MA — biotechnology — 2015–2016; $90.6M reported sold to 7 investors), Adhera Therapeutics, Inc. (Wake Forest, NC — pharmaceuticals — 2010–2012; $44M reported sold to 97 investors) and Cequent Pharmaceuticals Inc (Cambridge, MA — pharmaceuticals — 2009; $2.65M reported sold to 5 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 7 years. Across those companies the filings report $137.3M sold in total.
Listed alongside Peter Parker (3 shared filings), Chiang J. Li (2 shared filings), Daniel F. Flynn, Ph.D. (2 shared filings), Dennis Walsh (2 shared filings), Gregory Sessler (2 shared filings) and 17 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Michael. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 9 bankruptcy cases matching the name listed in Key records below.
What this means 11 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Michael Taylor and found 11 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.